6BDM
Crystal structure of human CYP3A4 bound to an inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 8.2.2 |
Synchrotron site | ALS |
Beamline | 8.2.2 |
Temperature [K] | 103 |
Detector technology | CCD |
Collection date | 2016-08-13 |
Detector | MARRESEARCH |
Wavelength(s) | 1.0 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 77.290, 101.410, 127.370 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 66.076 - 2.600 |
R-factor | 0.2043 |
Rwork | 0.201 |
R-free | 0.27450 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5vcc |
RMSD bond length | 0.010 |
RMSD bond angle | 1.198 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX ((1.11.1_2575)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 79.330 | 2.740 |
High resolution limit [Å] | 2.600 | 2.600 |
Rmerge | 0.079 | 3.396 |
Rpim | 0.042 | 1.767 |
Number of reflections | 15756 | 2258 |
<I/σ(I)> | 7.6 | 0.4 |
Completeness [%] | 99.9 | 100 |
Redundancy | 4.5 | 4.6 |
CC(1/2) | 0.999 | 0.303 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | MICROBATCH | 6.7 | 293 | PEG 3350, malonate |